Insider Transactions in Q3 2020 at Harrow Health, Inc. (HROW)
Insider Transaction List (Q3 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 28
2020
|
Anthony Principi Director |
BUY
Exercise of conversion of derivative security
|
Direct |
93,798
+50.0%
|
-
|
|
Jul 12
2020
|
Opaleye Management Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
20,900
+1.04%
|
$83,600
$4.99 P/Share
|
|
Jul 11
2020
|
Opaleye Management Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
46,800
+1.64%
|
$187,200
$4.96 P/Share
|
|
Jul 10
2020
|
Opaleye Management Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
45,000
+1.6%
|
$180,000
$4.98 P/Share
|
|
Jul 09
2020
|
Opaleye Management Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
30,000
+2.31%
|
$120,000
$4.83 P/Share
|
|
Jul 08
2020
|
Opaleye Management Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
65,000
+2.36%
|
$260,000
$4.99 P/Share
|
|
Jul 07
2020
|
Opaleye Management Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
41,300
+1.55%
|
$206,500
$5.18 P/Share
|